In this presentation, we will use a case-based approach to discuss the clinical finding, cytologic and histologic features, differential diagnoses, and pathogenesis of 3 histiocytic disorders involving bone marrow – 1. Precursor-targeted Immune Mediated Anemia (PIMA); 2. Hemophagocytic Lymphohistiocytosis (HLH); and 3. Hemophagocytic Histiocytic Sarcoma (HHS). Considering that various features of these conditions are often overlapping, the distinction between them can be challenging. A modified algorithm for approach to anemia will be used to help us in understanding where these reactive and neoplastic disorders fall in terms of their impact on hematopoiesis. The veterinary literature as it relates to these disorders (PIMA, HLH, and HS references cited below) and mimics of these disorders also will be addressed. In this presentation, we will use a case-based approach to discuss the clinical finding, cytologic and histologic features, differential diagnoses, and pathogenesis of 3 histiocytic disorders involving bone marrow – 1. Precursor-targeted Immune Mediated Anemia (PIMA); 2. Hemophagocytic Lymphohistiocytosis (HLH); and 3. Hemophagocytic Histiocytic Sarcoma (HHS). Considering that various features of these conditions are often overlapping, the distinction between them can be challenging. A modified algorithm for approach to anemia will be used to help us in understanding where these reactive and neoplastic disorders fall in terms of their impact on hematopoiesis. The veterinary literature as it relates to these disorders (PIMA, HLH, and HS references cited below) and mimics of these disorders also will be addressed.
Learning Objectives:
Upon completion, participant will be able list the 4 distinct bone marrow patterns seen in precursor-targeted immune mediated anemia (PIMA) and describe consistent CBC findings.
Upon completion, participant will be able to describe distinguising laboratory data that are consistentt with a diagnosis of hemophagocytic histioocytic sarcoma (HHS).
Upon completion, participant will be able to list various underlying causes of hemophagocytic lymphohistiocytosiss (HLH),